Tuesday, 13th November 2018, Brussels
09:00-16:15
Meeting Venue
Novotel Brussels Airport
Leonardo Da Vincilaan 25, 1831 Zaventem, Belgium
Final Program
Part I. Administration, formal aspects of planned/ongoing activitities, election
09:00-09:10 Welcome note (Dobbelaere, Kölker)
09:10-09:35 Dissemination and website revision (Dobbelaere) 
09:35-10:00 Spokesman’s report (Dionisi Vici)
10:00-10:15 European Post-Authorisation Registry for Ravicti® (RRPE): update (Gleich, Kölker)
10:15-10:30 Coffee break
10:30-11:00 U-IMD and collaboration with MetabERN and ERKNet (Gleich, Kölker)
11:00-11:20 Advantages and limitations of available nosologies for IMDs (Gleich, Kölker)
11:20-11:40 Kaleido’s approach to urea cycle disorders (Kaleido Biosciences)
11:40-12:15 Elections: Scientific Board (Dionisi Vici)
12:15-13:00 Lunch
Part II. Publication and research projects
13:00-13:30 Long-term outcome in individuals with cblA vs. mut0 deficiency (Hörster)
13:30-14:00 Severity score for methylmalonic and propionic aciduria (Chapman)
14:30-14:45 Coffee break
14:45-15:15 Genotype phenotype correlation in citrullinemia type I (Zielonka)
15:15-15:45 Evidence-based recommendations for isovaleric aciduria (Thimm, Dobbelaere)
15:45-16:15 Final discussion, wrap-up, next meeting
16:15 Farewell